Introducing FLUENT's New Cannabis Concentrates Line
Vertically integrated cannabis company Cansortium Inc is making waves in the industry with its latest launch—the Hyer Kind cannabis concentrate line. Operating under the familiar FLUENT brand, this new product line is available exclusively at all FLUENT dispensaries across the state.
Hyer Kind: A New Era for Concentrates
The Hyer Kind line features premium offerings, including cured badder, crumble, and cured resin cartridges. These products have been designed specifically to support the wellness routines of medical marijuana patients, who are increasingly showing interest in cannabis concentrates.
Insights from Leadership on Product Development
Robert Beasley, the CEO of Cansortium, expressed enthusiasm regarding this milestone. He noted, "As FLUENT's first brand dedicated exclusively to concentrates, Hyer Kind represents a significant step in our mission. We take pride in our brand and are confident that consumers in Florida will appreciate the quality of our new offerings. Through our careful selection of whole flower and advanced extraction methods, we aim to set new standards for flavor, quality, and innovation in the cannabis market."
Production Techniques Ensuring Quality
The Hyer Kind products highlight a commitment to full-spectrum flavor derived from cannabis. The development process includes selecting high-quality whole flowers and using advanced extraction methods such as hydrocarbon and solventless techniques. Live ice-water extraction also ensures that the potency and quality of the cannabis are preserved for medical marijuana patients.
Market Expansion Plans and Pricing Strategy
While the initial launch focuses on Florida, there are plans to expand the Hyer Kind brand into additional markets, including New York. Currently, patients in Florida can purchase the cured badder and resin cartridges (0.5g) for $50, while the crumble variant is available for $45. The brand is also set to diversify its portfolio with more concentrate options in the near future.
Implications of Recent Mergers
In an important recent development, the New York Cannabis Control Board has approved a merger between Cansortium and RIV Capital. This merger is expected to conclude by the end of 2024, positioning the newly combined company to effectively serve approximately 25% of the U.S. population, with an expansive network of cultivation facilities and retail dispensaries.
Current Share Performance
On the stock market, shares of Cansortium saw a 5.26% decline, ending the last market session at $0.900 per share. This performance comes as the company navigates a rapidly evolving cannabis landscape.
Frequently Asked Questions
What is the Hyer Kind cannabis line?
The Hyer Kind cannabis line is a new range of concentrates launched by FLUENT under Cansortium Inc, specifically designed for medical marijuana patients.
What products are available in the Hyer Kind line?
The line includes cured badder, crumble, and cured resin cartridges, all aimed at enhancing wellness for users.
When will the Hyer Kind products be available in other markets?
While initially launched in Florida, there are plans to expand Hyer Kind into other markets, including New York.
How are the Hyer Kind products made?
These products are made using high-quality whole flowers and advanced extraction techniques to ensure maximum flavor and potency.
What is the stock ticker for Cansortium Inc?
The stock ticker for Cansortium Inc is TIUM on the CSE and CNTMF on the OTCQB.
